CLLS

NASDAQStock

Cellectis S.A.

$3.42-0.39 (-10.13%)

52-Week Range

$1.15

$5.35

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.85

Volume

117.0K

Avg Volume

58.8K

Performance

-14.40%

-28.85%

+11.37%

YTD

-30.62%

+156.15%

+68.18%

-84.70%

Price Chart

ETF Exposure

CLLS is held by 3 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ERSX	ERShares NextGen Entrepreneurs ETF	2.38%	61,863	$1.9M	$9.0M	0.75%
ENTR	L&G Energy Transition Commodities UCITS ETF	0.88%	71,529	$717K	$46.4M	0.65%
IBB	iShares Biotechnology ETF	0.02%	344,462	$1.3M	$8.50B	0.44%

About CLLS ETF Exposure

Cellectis S.A. (CLLS) is held by 3 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.42. Investors can gain exposure to CLLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CLLS, sorted by portfolio weight.